Menu Back toSESSION-1-Japanese-Standards-for-Biological-Raw-Materials-in-the-Development-of-Regenerative-Medical-Products-From-Industry-Viewpoints

4th DIA Cell and Gene Therapy Products Symposium in Japan

All prices are exclusive of 10% Japanese consumption tax

SESSION 1 - Japanese Standards for Biological Raw Materials in the Development of Regenerative Medical Products: From Industry Viewpoints

Session Chair(s)

Yoji  Sato, PhD

Yoji Sato, PhD

  • Head, Division of Cell-Based Therapeutic Products
  • National Institute of Health Sciences, Japan
We sometimes face to regulatory challenges related to the Standards for Biological Raw Materials, in the development of regenerative medical products in Japan. In this session, after the introduction of the background and perspectives of the Standards, key operational issues and possible solutions will be discussed during the panel discussions from companies’ viewpoints by the representatives from each industry group.

Speaker(s)

Yoji  Sato, PhD

The Background and Perspectives of the Standards for Biological Raw Materials

Yoji Sato, PhD

  • Head, Division of Cell-Based Therapeutic Products
  • National Institute of Health Sciences, Japan

Contact us


Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574